Effect of GM-CSF on CAPA-IVM System Success Rates in PCOS
Launched by MỸ ĐỨC HOSPITAL · Feb 24, 2021
Trial Information
Current as of June 17, 2025
Unknown status
Keywords
ClinConnect Summary
In-vitro maturation (IVM) of human oocytes obtained from minimally stimulated or unstimulated ovaries offers a more "patient friendly" treatment option than the conventional Assisted Reproductive Technology (ART) treatment with controlled ovarian hyperstimulation (COH).
Typically, IVM will be offered to women with polycystic ovaries (PCO/PCOS), or to patients with an excellent ovarian reserve, i.e. a high antral follicle count. IVM treatment is characterized by minimal administration of FSH or HMG and NO HCG ovulation trigger.
The IVM approach is less disruptive to patients' daily life th...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed as PCOS using Rotterdam criteria (AFC=25 or the ovarian volume \>10ml)
- • Agree to participate in the study
- Exclusion Criteria:
- • No major uterine or ovarian abnormalities
- • Endometriosis grade 2 or upper
- • Severe OAT (concentration \<1 million/ml, motility \<10%), surgical sperm
About Mỹ đức Hospital
Mỹ Đức Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong emphasis on ethical practices and patient safety, the hospital collaborates with reputable research organizations and healthcare professionals to conduct studies across various therapeutic areas. Committed to excellence in clinical research, Mỹ Đức Hospital leverages its state-of-the-art facilities and experienced staff to contribute valuable insights that enhance medical knowledge and treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, , Vietnam
Patients applied
Trial Officials
Tuong M Ho, MD
Principal Investigator
Hope Research Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials